AUROPHARMA.BOAUROPHARMA.BO
LOADING
|||
R&D Expense Growth Trend
Trending higher.
Left:
||||
Year-over-year research & development expense growth
Latest
12.81%
Near historical average
Average (39q)
12.37%
Historical baseline
Range
High:313.39%
Low:-100.00%
Volatility
3343.1%
High variability
| Period | Value |
|---|---|
| Q3 2025 | 12.81% |
| Q2 2025 | -78.31% |
| Q1 2025 | 0.00% |
| Q4 2024 | 0.00% |
| Q3 2024 | 0.00% |
| Q2 2024 | -100.00% |
| Q1 2024 | 0.00% |
| Q4 2023 | 0.00% |
| Q3 2023 | 0.00% |
| Q2 2023 | -100.00% |
| Q1 2023 | 249.91% |
| Q4 2022 | 0.00% |
| Q3 2022 | -100.00% |
| Q2 2022 | -80.92% |
| Q1 2022 | 313.39% |
| Q4 2021 | -1.50% |
| Q3 2021 | 11.45% |
| Q2 2021 | -76.51% |
| Q1 2021 | 290.28% |
| Q4 2020 | -4.17% |
| Q3 2020 | 60.12% |
| Q2 2020 | -73.53% |
| Q1 2020 | 279.74% |
| Q4 2019 | 13.59% |
| Q3 2019 | -8.27% |
| Q2 2019 | -72.02% |
| Q1 2019 | 241.12% |
| Q4 2018 | 17.44% |
| Q3 2018 | 0.00% |
| Q2 2018 | -100.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | -100.00% |
| Q1 2017 | 0.00% |
| Q4 2016 | 0.00% |
| Q3 2016 | 0.00% |
| Q2 2016 | -100.00% |
| Q1 2016 | 0.00% |
| Q4 2015 | 0.00% |